EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells

Clinical and Experimental Metastasis

Volumn 14, Issue 4, 1996, Pages 409-418

  Turner, Timothy ^b   Chen, Philip ^b   Goodly, Lyndon J ^b   Wells, Alan ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Epidermal growth factor receptor; Phospholipase C; Tumor progression

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PROSTATE CARCINOMA; TUMOR GROWTH;

ANIMALS; CARCINOMA; CELL DIVISION; CELL MOVEMENT; ENZYME INHIBITORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOMYCIN; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PHOSPHOLIPASE C; PROSTATE; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0029960701     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00123400     Document Type: Article

References (50)

1. Partin AW and Coffey DS, 1994, Benign and Malignant Prostatic Neoplasms: human studies. San Diego, California: Academic Press.
2. Sandberg AA, 1992, Cytogenetic and Molecular Genetic Aspects of Human Prostate Cancer: primary and metastatic. New York: Plenum Press.
3. Geldof AA and Rao BR, 1990, Factors in prostate cancer metastasis. Anticancer Res, 10, 1303-6.
4. Linehan WM, 1995, Inhibition of prostate cancer metastasis: a critical challenge ahead. J Natl Cancer Inst, 87, 331-2.
5. Gittes RF, 1991, Carcinoma of the prostate. N Engl J Med, 324, 236-45.
6. Surya BV and Provet JA, 1989, Manifestations of advanced prostate cancer: prognosis and treatment. J Urol, 142, 921-8.
7. McKeehan WL, 1986, Growth factors spawn new cell cultures. Nature, 321, 629-30.
8. Chaproniere DM and Webber MM, 1985, Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF or insulin-induced proliferation of prostatic epithelium. J Cell Physiol, 122, 249-53.
9. Eaton CL, Davies P and Phillips MEA, 1988, Growth factor involvement and oncogene expression in prostatic tumors. J Ster Biochem, 30, 341-5.
10. Marti U, Burwen SJ and Jones AL, 1989, Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology, 9, 126-38.
11. Connolly JM and Rose DP, 1989, Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate, 15, 177-86.
12. Nishi N, Matuo Y and Wada F, 1988, Partial purification of a major type of rat prostatic growth factor: characterization as an epidermal growth factor-related mitogen. Prostate, 13, 209-20.
13. Wilding G, Valverius E, Knabbe C and Gelmann EP, 1989, Role of transforming growth factor-α in human prostate cancer cell growth. Prostate, 15, 1-12.
14. Liu X-H, Wiley HS and Meikle AW, 1993, Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming gowth factor-α (TGF-α) and epidermal growth factor (EGF)/TGF-α receptor. J Clin Endocr Metab, 77, 1472-8.
15. Aaronson SA, 1991, Growth factors and cancer. Science, 254, 1146-53.
16. Schlegel J, Merdes A, Stumm G, et al., 1994, Amplification of the epidermal growth factor receptor gene correlates with different growth behavior in human glioblastoma. Int J Cancer, 56, 72-7.
17. Collins VP, 1993, Amplified genes in human gliomas. Sem Cancer Biol, 4, 27-32.
18. Yasui W, Sumiyoshi H, Hata J, et al., 1988, Expression of epidermal growth factor receptor in human gastric and colon carcinomas. Cancer Res, 48, 137-41.
19. Neal DE, Marsh C, Bennett MK, et al., 1985, Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet, i, 366-8.
20. Nguyen PL, Swanson PE, Jaszcz W, et al., 1994, Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am J Clin Pathol, 101, 166-76.
21. Klijn JG, Berns PM, Schmitz PI and Foekens JA, 1992, The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev, 13, 3-17.
22. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ and Harris AL, 1987, Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, i, 1398-402.
23. Rudinsky R, Risin S, Fan D, et al., 1995, Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res, 1, 19-31.
24. Lubrano C, Petrangeli E, Catizone A, et al., 1989, Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia. J Ster Biochem, 34, 499-504.
25. Morris GL and Dodd JG, 1990, Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol, 143, 1272-4.
26. Davies P and Eaton CL, 1989, Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate, 14, 123-32.
27. Myers RB, Kudlow JE and Grizzle WE, 1993, Expression of transforming growth factor alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Modern Pathol, 6, 733-7.
28. Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M and Dodd JG, 1993, Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Molec Cell Biochem, 126, 151-8.
29. Tillotson JK and Rose DP, 1991, Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett, 60, 109-12.
30. Haugen DRF, Akslen LA, Varhaug JE and Lillehaug JR, 1993, Demonstration of a TGF-α-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. Int J Cancer, 55, 37-43.
31. Hamada J, Nagayasu H, Takayama M, Kawano T, Hosokawa M and Takeichi N, 1995, Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells. Cancer Lett, 89, 161-7.
32. Chakrabarty S, Rajagopal S and Huang S, 1995, Expression of antisense epidermal growth factor receptor RNA dowmnodulates the malignant behavior of human colon cancer cells. Clin Exp Metastasis, 13, 191-5.
33. Kore M, Chandrasekar B, Yamanaka Y, et al., 1992, Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest, 90, 1352-60.
34. Stone K, Mickey DD, Wunderli H, Mickey GH and Paulson DF, 1978, Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer, 21, 274-81.
35. Connolly JM and Rose DP, 1992, Interactions between epidermal growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line. Prostate, 20, 151-8.
36. Xie H, Turner T, Wang M-H, Singh RK, Siegal GP and Wells A, 1995, In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis, 13, 407-19.
37. Chen P, Gupta K and Wells A, 1994, Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation hut is separable from mitogenesis. J Cell Biol, 124, 547-55.
38. Chen P, Xie H, Sekar MC, Gupta KB and Wells A, 1994, Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but MAP kinase activity is not sufficient for induced cell movement. J Cell Biol, 127, 847-57.
39. Bleasdale JE, Thakur NR, Gremban RS, et al., 1990, Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharm Exp Ther, 255, 756-68.
40. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J and Modest EJ, 1992, Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res, 52, 2835-40.
41. Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN and Rosenfeld MG, 1990, Ligand-induced transformation by a non-internalizing EGF receptor. Science, 247, 962-4.
42. Ullrich A, Coussens L, Hayflick JS, et al., 1984, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 307, 418-25.
43. Welsh JB, Gill GN, Rosenfeld MG and Wells A, 1991, A negative feedback loop attenuates EGF-induced morphological changes. J Cell Biol, 114, 533-43.
44. Masui H, Wells A, Lazar CS, Rosenfeld MG and Gill GN, 1991, Enhanced tumorigenesis of NR6 cells which express non-downregulating epidermal growth factor receptors. Cancer Res, 51, 6170-5.
45. Service NTI, 1981-82, Registry of Toxic Effects of Chemical Substance. Washington DC: US Department of Commerce.
46. Peterson G and Barnes S, 1993, Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor lyrosine autophosphorylation. Prostate, 22, 335-45.
47. Knox JD, Mack CF, Powell WC, Bowden GT and Nagle RB, 1993, Prostate tumor cell invasion: a comparison of orthotopic and ectopic models. Invasion and Metastasis, 13, 325-31.
48. Powell WC, Knox JD, Navre M, et al., 1993, Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res, 53, 417-22.
49. Sunada H, Magun BE, Mendelsohn J and MacLeod CL, 1986, Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc Natl Acad Sci. USA, 83, 3825-9.
50. Chen P, Xie H and Wells A, 1996, Mitogenic signaling from the EGF receptor is attenuated by a motility-associated phospholipase C-γ/protein kinase C feedback mechanism. Molec Biol Cell, 7, in press.